Literature DB >> 15197236

Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.

Terese Dajotoy1, Pia Andersson, Anders Bjartell, Claes-Göran Löfdahl, Hans Tapper, Arne Egesten.   

Abstract

Eosinophils participate in allergic inflammation, where expression of T helper cell type 2 (Th2) cytokines such as interleukin (IL)-4 and IL-5 are seen. However, eosinophils sometimes accumulate during disease with expression of Th1 cytokines [i.e., interferon-gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and IL-1beta]. In this study, we investigated whether eosinophils can respond with expression of the IFN-inducible C-X-C chemokines monokine induced by IFN-gamma [MIG; CXC chemokine ligand 9 (CXCL9)], IFN-gamma-inducible protein (IP-10/CXCL10), and IFN-inducible T cell alpha chemoattractant (I-TAC/CXCL11). These chemokines share the ability to recruit and activate T cells and natural killer cells to sites of inflammation. We found that IFN-gamma induced rapid and sustained gene expression of MIG, IP-10, and I-TAC in eosinophils, as detected by quantitative reverse transcriptase-polymerase chain reaction. During incubation, IFN-gamma-stimulated eosinophils released MIG and IP-10, as detected by enzyme-linked immunosorbent assay, while I-TAC could not be detected in the medium. TNF-alpha but not IL-1beta enhanced the IFN-gamma-induced production of MIG and IP-10. Conversely, addition of the Th2 cytokine IL-4 down-regulated IFN-gamma-induced synthesis of MIG and IP-10 in eosinophils. Crohn's disease is characterized by a Th1-polarized inflammation and presence of eosinophils. In lesions from this disease, MIG was detected in eosinophils by immunohistochemistry. Taken together, the results point to immunoregulatory roles for eosinophils during some diseases with Th1-polarized inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197236     DOI: 10.1189/jlb.0803379

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

2.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

3.  CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?

Authors:  Francesca Gotsch; Roberto Romero; Lara Friel; Juan Pedro Kusanovic; Jimmy Espinoza; Offer Erez; Nandor Gabor Than; Pooja Mittal; Samuel Edwin; Bo Hyun Yoon; Chong Jai Kim; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-11

Review 4.  Functions of tissue-resident eosinophils.

Authors:  Peter F Weller; Lisa A Spencer
Journal:  Nat Rev Immunol       Date:  2017-09-11       Impact factor: 53.106

5.  NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines.

Authors:  Sunil Yeruva; Giuliano Ramadori; Dirk Raddatz
Journal:  Int J Colorectal Dis       Date:  2007-11-28       Impact factor: 2.571

Review 6.  Immunoregulatory roles of eosinophils: a new look at a familiar cell.

Authors:  P Akuthota; H B Wang; L A Spencer; P F Weller
Journal:  Clin Exp Allergy       Date:  2008-08       Impact factor: 5.018

7.  Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Sara Cioccolo; Rossana Scrivo; Manuela Morreale; Simona Pontecorvo; Federica Ferrari; Giovanni Di Nardo; Lucia Nencioni; Silvia Carluccio; Guido Valesini; Ada Francia; Salvatore Cucchiara; Anna Teresa Palamara; Valeria Pietropaolo
Journal:  Virol J       Date:  2013-09-30       Impact factor: 4.099

Review 8.  Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity.

Authors:  Francis Davoine; Paige Lacy
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

Review 9.  Engineered Cytokine Signaling to Improve CAR T Cell Effector Function.

Authors:  Matthew Bell; Stephen Gottschalk
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

10.  MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis.

Authors:  Damian Tworek; Piotr Kuna; Wojciech Młynarski; Paweł Górski; Tadeusz Pietras; Adam Antczak
Journal:  Arch Med Sci       Date:  2013-08-26       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.